Literature DB >> 1324562

Diuresis and natriuresis following isotonic saline infusion in healthy young volunteers before, during, and after HDT.

C Drummer1, M Heer, F Baisch, C G Blomqvist, R E Lang, H Maass, R Gerzer.   

Abstract

In the present study the response to acute saline loading was investigated. During a 24-day study period six male subjects followed a standardized diet including a daily intake of 40 ml water and 125 mg NaCl per kg body weight. Before, during, and after a ten-day period of 6 degrees head down tilt (HDT) each volunteer received an intravenous 0.9% saline infusion of 22 ml/kg body weight over 20 minutes. HDT produced significant losses in body weight and in blood volume, but the responses to saline loading were similar during all phases of the study. Plasma levels of atrial natriuretic peptide (ANP) did not increase, while plasma levels of cyclic GMP increased by about 40% 90 minutes after each infusion. Urine flow nearly doubled during second hour post-infusion. Sodium excretion showed a 3-fold increase and remained elevated during the third hour, while potassium excretion was significantly reduced. Urinary excretion of cyclic GMP reached a peak during the second hour post-infusion. At the end of these short-term periods the cumulative water- and sodium-balance data disclosed that only about 20% of the infused water and less than 15% of the infused sodium was excreted during each experiment. In addition to the short-term renal response, urine flow and sodium excretion remained significantly elevated for more than 48 hours after each saline load. The long-term renal response was paralleled by an increased excretion of urinary cyclic GMP. HDT produced significant changes in body fluid distribution, but only minor changes in the regulatory responses to an acute saline load. We conclude from these data that the excretion of an acute isotonic saline load requires several days and that the renal response appears to be independent of the secretion of ANP from the heart.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Substances:

Year:  1992        PMID: 1324562

Source DB:  PubMed          Journal:  Acta Physiol Scand Suppl        ISSN: 0302-2994


  6 in total

Review 1.  [Perioperative fluid management: an analysis of the present situation].

Authors:  Y A Zausig; M A Weigand; B M Graf
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

Review 2.  From space to Earth: advances in human physiology from 20 years of bed rest studies (1986-2006).

Authors:  A Pavy-Le Traon; M Heer; M V Narici; J Rittweger; J Vernikos
Journal:  Eur J Appl Physiol       Date:  2007-07-28       Impact factor: 3.078

3.  A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer.

Authors:  Chun Kheng Khoo; Christopher J Vickery; Nicola Forsyth; Nina S Vinall; Ian A Eyre-Brook
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

4.  The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans.

Authors:  Matthias Jacob; Daniel Chappell; Klaus Hofmann-Kiefer; Tobias Helfen; Anna Schuelke; Barbara Jacob; Alexander Burges; Peter Conzen; Markus Rehm
Journal:  Crit Care       Date:  2012-05-16       Impact factor: 9.097

5.  Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx.

Authors:  Daniel Chappell; Dirk Bruegger; Julia Potzel; Matthias Jacob; Florian Brettner; Michael Vogeser; Peter Conzen; Bernhard F Becker; Markus Rehm
Journal:  Crit Care       Date:  2014-10-13       Impact factor: 9.097

6.  Intravenous Fluid Challenge Decreases Intracellular Volume: A Bioimpedance Spectroscopy-Based Crossover Study in Healthy Volunteers.

Authors:  Matthäus Ernstbrunner; Barbara Kabon; Oliver Zotti; Markus Zeitlinger; Carolin Berner; Georg Hinterholzer; Marcus Säemann; Florian Frommlet; Edith Fleischmann; Manfred Hecking
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.